Paul Worth

1.6k total citations
24 papers, 703 citations indexed

About

Paul Worth is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Paul Worth has authored 24 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Paul Worth's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (11 papers) and Genetic Neurodegenerative Diseases (10 papers). Paul Worth is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (11 papers) and Genetic Neurodegenerative Diseases (10 papers). Paul Worth collaborates with scholars based in United Kingdom, France and United States. Paul Worth's co-authors include Nicholas Wood, Paola Giunti, Christopher Gardner‐Thorpe, Caroline H. Williams‐Gray, Donald G. Grosset, Peter Dixon, Carl E Clarke, David A. Stewart, Gilles David and Alexis Brice and has published in prestigious journals such as Nature Genetics, Neurology and The American Journal of Human Genetics.

In The Last Decade

Paul Worth

23 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Worth United Kingdom 12 345 328 324 63 57 24 703
Michel Borg France 11 530 1.5× 290 0.9× 342 1.1× 48 0.8× 82 1.4× 12 862
Adriana Moro Brazil 14 339 1.0× 243 0.7× 265 0.8× 44 0.7× 35 0.6× 38 589
N. Gouider‐Khouja Tunisia 16 496 1.4× 236 0.7× 271 0.8× 91 1.4× 98 1.7× 47 879
Katarzyna Sieradzan United Kingdom 11 373 1.1× 263 0.8× 567 1.8× 75 1.2× 109 1.9× 22 917
Kuncheng Liu China 13 382 1.1× 122 0.4× 135 0.4× 68 1.1× 89 1.6× 76 559
Chiara Pane Italy 14 244 0.7× 337 1.0× 310 1.0× 15 0.2× 45 0.8× 38 633
Takayasu Mishima Japan 14 418 1.2× 110 0.3× 132 0.4× 64 1.0× 51 0.9× 61 601
Silvia Jesús Spain 17 510 1.5× 175 0.5× 194 0.6× 44 0.7× 143 2.5× 40 766
Barbara Jasińska‐Myga Poland 15 540 1.6× 138 0.4× 202 0.6× 41 0.7× 182 3.2× 29 710
Aaron Sturrock United Kingdom 9 368 1.1× 339 1.0× 489 1.5× 33 0.5× 32 0.6× 12 672

Countries citing papers authored by Paul Worth

Since Specialization
Citations

This map shows the geographic impact of Paul Worth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Worth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Worth more than expected).

Fields of papers citing papers by Paul Worth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Worth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Worth. The network helps show where Paul Worth may publish in the future.

Co-authorship network of co-authors of Paul Worth

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Worth. A scholar is included among the top collaborators of Paul Worth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Worth. Paul Worth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams‐Gray, Caroline H. & Paul Worth. (2023). Parkinson's disease and related conditions. Medicine. 51(9). 645–651. 2 indexed citations
2.
Ealing, John, et al.. (2015). THE KNOWN UK CASES OF ATAXIA TELANGIECTASIA-LIKE DISORDER (ATLD). Journal of Neurology Neurosurgery & Psychiatry. 86(11). e4.184–e4. 1 indexed citations
3.
Freed, Martin I., Donald G. Grosset, Paul Worth, et al.. (2014). Rapid Levodopa Augmentation Following Inhaled CVT-301 Results in Rapid Improvement in Motor Response When Administered to PD Patients in the OFF State (S7.007). Neurology. 82(10_supplement). 7 indexed citations
4.
Deane, Katherine, Richard Gray, Allan Clark, et al.. (2014). Adherence therapy improves medication adherence and quality of life in people with Parkinson's disease: a randomised controlled trial. International Journal of Clinical Practice. 68(8). 963–971. 36 indexed citations
5.
Macphee, Graeme J.A., К. Ray Chaudhuri, Anthony S. David, Paul Worth, & Brian Wood. (2013). Managing impulse control behaviours in Parkinson's disease: practical guidelines. British Journal of Hospital Medicine. 74(3). 160–166. 14 indexed citations
6.
Thomas, Sue, et al.. (2013). Developing an integrated care pathway: the process and its application to neurological conditions. British Journal of Neuroscience Nursing. 9(6). 292–300. 6 indexed citations
7.
Worth, Paul. (2013). When the going gets tough: how to select patients with Parkinson's disease for advanced therapies. Practical Neurology. 13(3). 140–152. 50 indexed citations
8.
Worth, Paul, Venkataramanan Srinivasan, Anna Jo Bodurtha Smith, et al.. (2012). Very mild presentation in adult with classical cellular phenotype of ataxia telangiectasia. Movement Disorders. 28(4). 524–528. 26 indexed citations
9.
Needham, Edward & Paul Worth. (2012). Parkinson's disease: a guide to pharmacological management. Prescriber. 23(5). 21–31. 5 indexed citations
10.
Deane, Katherine, Richard Gray, Paul Worth, et al.. (2011). The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial. Trials. 12(1). 251–251. 10 indexed citations
11.
Giunti, Paola, Henry Houlden, Christopher Gardner‐Thorpe, et al.. (2011). Spinocerebellar ataxia type 11. Handbook of clinical neurology. 103. 521–534. 7 indexed citations
12.
Clarke, Carl E, Paul Worth, Donald G. Grosset, & David A. Stewart. (2009). Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease. Parkinsonism & Related Disorders. 15(10). 728–741. 63 indexed citations
13.
Houlden, Henry, J J Johnson, Christopher Gardner‐Thorpe, et al.. (2008). Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11 (vol 39, pg 1434, 2007). UCL Discovery (University College London). 18 indexed citations
14.
Worth, Paul. (2007). A perspective on the current issues in the diagnosis of Parkinson's disease. British Journal of Hospital Medicine. 68(5). S6–S15. 2 indexed citations
15.
Houlden, Henry, Janel Johnson, Christopher Gardner‐Thorpe, et al.. (2007). Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nature Genetics. 39(12). 1434–1436. 130 indexed citations
16.
Worth, Paul. (2005). Syncope associated with pain as the presenting feature of neck malignancy: failure of cardiac pacemaker to prevent attacks in two cases. Journal of Neurology Neurosurgery & Psychiatry. 76(9). 1301–1303. 8 indexed citations
17.
Cotton, Sarah, et al.. (2004). Clotting Factors in Patients with Acute and Chronic Gout. Journal of Medical Sciences(Faisalabad). 5(1). 47–51. 1 indexed citations
18.
Worth, Paul, Eimear Dunne, Andrea H. Németh, & Nicholas Wood. (1999). Autosomal dominant cerebellar ataxia type III: No evidence for a large pathological CAG repeat expansion in the SCA 11 gene.. UCL Discovery (University College London). 1 indexed citations
19.
Worth, Paul, et al.. (1999). Autosomal Dominant Cerebellar Ataxia Type III: Linkage in a Large British Family to a 7.6-cM Region on Chromosome 15q14-21.3. The American Journal of Human Genetics. 65(2). 420–426. 93 indexed citations
20.
Giunti, Paola, Giovanni Stévanin, Paul Worth, et al.. (1999). Molecular and Clinical Study of 18 Families with ADCA Type II: Evidence for Genetic Heterogeneity and De Novo Mutation. The American Journal of Human Genetics. 64(6). 1594–1603. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Borg Breakdown of academic impact, for papers by Adriana Moro Breakdown of academic impact, for papers by N. Gouider‐Khouja Breakdown of academic impact, for papers by Katarzyna Sieradzan Breakdown of academic impact, for papers by Kuncheng Liu Breakdown of academic impact, for papers by Chiara Pane Breakdown of academic impact, for papers by Takayasu Mishima Breakdown of academic impact, for papers by Silvia Jesús Breakdown of academic impact, for papers by Barbara Jasińska‐Myga Breakdown of academic impact, for papers by Aaron Sturrock
Rankless by CCL
2026